The common pathologic processes manifest as Alzheimer's disease (AD) likely impact on very basic aspects of cell biology. In the investigation of glial and neuronal interactions, cell culture approaches offer a degree (and rate) of manipulation unavailable in other models. Therefore, we propose to test in tissue culture various aspects of the cytokine cycle theoretically operative in AD. Primary microglial cultures, neuronal cultures, and relevant cell lines will be utilized to assay the effects of S100beta and Abeta on parameters deemed crucial by the other projects to the initiation of progression of AD and related conditions. The essential hypothesis driving this project is that products of betaAPP (including Abeta) stimulate glial responses exacerbated by the glial cytokines S100beta and IL-1 that result in excitotoxicity. Furthermore, we see the rapid screening opportunities available in cell culture as an indispensable tool for testing anti-inflammatory agents against an effect of Abeta that may create dire complications for immunization therapies for AD. Therefore, this project will focus on the following specific aims: (1) Characterize the molecular mechanisms through which S100beta control s the betaAPP gene promoter, (2) determine the potential contribution of excitotoxi8c amino acids to microglial toxicity, (3) determine the effectiveness of anti-inflammatory cytokines and drugs against Abeta induction of a key cytokine, and (4) determine the biological effects of polymorphisms in the IL-1 gene. Accomplishment of these goals will be of direct benefit to the identification of basic elements of AD pathogenesis and potential sites for therapeutic intervention.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
2P01AG012411-07
Application #
6434701
Study Section
Special Emphasis Panel (ZAG1)
Project Start
1995-06-01
Project End
2007-05-31
Budget Start
Budget End
Support Year
7
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of Arkansas for Medical Sciences
Department
Type
DUNS #
City
Little Rock
State
AR
Country
United States
Zip Code
72205
Kiaei, Mahmoud; Balasubramaniam, Meenakshisundaram; Govind Kumar, Vivek et al. (2018) ALS-causing mutations in profilin-1 alter its conformational dynamics: A computational approach to explain propensity for aggregation. Sci Rep 8:13102
Zafar, Maroof K; Maddukuri, Leena; Ketkar, Amit et al. (2018) A Small-Molecule Inhibitor of Human DNA Polymerase ? Potentiates the Effects of Cisplatin in Tumor Cells. Biochemistry 57:1262-1273
Janganati, Venumadhav; Ponder, Jessica; Balasubramaniam, Meenakshisundaram et al. (2018) MMB triazole analogs are potent NF-?B inhibitors and anti-cancer agents against both hematological and solid tumor cells. Eur J Med Chem 157:562-581
Ayyadevara, Srinivas; Ganne, Akshatha; Hendrix, Rachel D et al. (2018) Functional assessments through novel proteomics approaches: Application to insulin/IGF signaling in neurodegenerative disease'. J Neurosci Methods :
Balasubramaniam, Meenakshisundaram; Ayyadevara, Srinivas; Shmookler Reis, Robert J (2018) Structural insights into pro-aggregation effects of C. elegans CRAM-1 and its human ortholog SERF2. Sci Rep 8:14891
Liu, A K L; Lim, E J; Ahmed, I et al. (2018) Review: Revisiting the human cholinergic nucleus of the diagonal band of Broca. Neuropathol Appl Neurobiol 44:647-662
Lamture, Gauri; Crooks, Peter A; Borrelli, Michael J (2018) Actinomycin-D and dimethylamino-parthenolide synergism in treating human pancreatic cancer cells. Drug Dev Res 79:287-294
Balasubramaniam, Meenakshisundaram; Reis, Robert J Shmookler; Ayyadevara, Srinivas et al. (2017) Involvement of tRNAs in replication of human mitochondrial DNA and modifying effects of telomerase. Mech Ageing Dev 166:55-63
Barger, Steven W (2016) Gene regulation and genetics in neurochemistry, past to future. J Neurochem 139 Suppl 2:24-57
Mao, Xianrong; Phanavanh, Bounleut; Hamdan, Hamdan et al. (2016) NF?B-inducing kinase inhibits NF?B activity specifically in neurons of the CNS. J Neurochem 137:154-63

Showing the most recent 10 out of 140 publications